XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating activities:    
Net loss $ (18,584) $ (15,516)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization expense 591 537
Non-cash interest 651 296
Stock-based compensation 656 625
Provision for bad debt expense 1,290 0
Loss on debt extinguishment 0 1,333
Employee stock purchase plan compensation 0 103
Changes in operating assets and liabilities:    
Accounts receivable 1,795 (469)
Inventory (1,037) (1,954)
Prepaid expenses and other current assets 244 288
Accounts payable 150 2,257
Accrued expenses and contract liabilities (1,006) (368)
Net cash used in operating activities (15,250) (12,868)
Investing Activities:    
Purchases of property and equipment 0 (30)
Net cash used in investing activities 0 (30)
Financing activities:    
Proceeds from issuance of term debt, net of issuance costs 0 19,207
Repayment of term-loan debt (5,000) (10,812)
Proceeds from PPP Loan 1,775 0
Proceeds from borrowing from line of credit 760 1,106
Repayments of borrowing from line of credit (2,258) (306)
Proceeds from sale of common stock, net of offering costs 16,366 2,410
Proceeds from sale of common stock under employee stock purchase plan 21 0
Proceeds from warrant and option exercises 3,469 65
Net cash provided by financing activities 15,133 11,670
Net decrease in cash and cash equivalents (117) (1,228)
Cash and cash equivalents at beginning of period 17,311 16,523
Cash and cash equivalents at end of period 17,194 15,295
Supplemental cash flow disclosures:    
Cash paid for interest 715 245
Supplemental disclosure of non-cash investing and financing activities:    
Property and equipment costs incurred but not paid included in accounts payable and accrued expenses 0 9
Fair value of warrants issued with debt 0 630
Transfer of instruments and servers from inventory to property and equipment 1,191 0
Issue common stock for covenant waiver 300
Fair value of stock issued with debt $ 0 $ 202